The Programme in Cancer and Stem Cell Biology (CSCB) is one of five founding Signature Research Programmes of the Duke-NUS Medical School. CSCB has a broad scope of research. Our faculty engage in hypothesis-driven basic science and disease-oriented investigation, as well as active drug discovery and innovative clinical trials. We are committed to translation of key findings, and our faculty have moved basic science discoveries from bench to bedside, with clinical trials in multiple cancers driven by discoveries made by CSCB scientists.

Back
Tuesday, 01 Jun, 2021

Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation

Link to paper

Nisha Padmanabhan, Huang Kie Kyon, Arnoud Boot, Kevin Lim, Supriya Srivastava, Shuwen Chen, Zhiyuan Wu, Hyung-Ok Lee, Vineeth T Mukundan, Charlene Chan, Yarn Kit Chan, Ong Xuewen, Jason J Pitt, Zul Fazreen Adam Isa, Manjie Xing, Ming Hui Lee, Angie Lay Keng Tan, Shamaine Ho Wei Ting, Micah A Luftig, Dennis Kappei, Warren D Kruger, Jinsong Bian, Ying Swan Ho, Ming Teh, Steve George Rozen, Patrick Tan

 

Back
Tuesday, 01 Jun, 2021

Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation

Link to paper

Nisha Padmanabhan, Huang Kie Kyon, Arnoud Boot, Kevin Lim, Supriya Srivastava, Shuwen Chen, Zhiyuan Wu, Hyung-Ok Lee, Vineeth T Mukundan, Charlene Chan, Yarn Kit Chan, Ong Xuewen, Jason J Pitt, Zul Fazreen Adam Isa, Manjie Xing, Ming Hui Lee, Angie Lay Keng Tan, Shamaine Ho Wei Ting, Micah A Luftig, Dennis Kappei, Warren D Kruger, Jinsong Bian, Ying Swan Ho, Ming Teh, Steve George Rozen, Patrick Tan